Biochemical and Pharmacological Analyses of HIV-1 Integrase Flexible Loop Mutants Resistant to Raltegravir [PDF]
Mathieu Métifiot+5 more
openalex +1 more source
Exacerbation of depression associated with starting raltegravir: a report of four cases
Marianne Harris+2 more
openalex +1 more source
Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961) [PDF]
Joseph J. Eron+12 more
openalex +1 more source
Raltegravir for postexposure prophylaxis following occupational exposure to HIV
Marc Siegel+2 more
openalex +1 more source
Resistance to inhibitors of the human immunodeficiency virus type 1 integration
This review will summarize the role of integrase in HIV-1 infection, the mechanism of integrase inhibitors and resistance with an emphasis on raltegravir (RAL), the first integrase inhibitor licensed to treat HIV-1 infection.
Daria J. Hazuda, PhD
doaj
Etravirine–raltegravir, a marked interaction in HIV-1-infected patients: about four cases
Amélie Menard+7 more
openalex +1 more source
Short‐Course Raltegravir Intensification Does Not Reduce Persistent Low‐Level Viremia in Patients with HIV‐1 Suppression during Receipt of Combination Antiretroviral Therapy [PDF]
Deborah McMahon+12 more
openalex +1 more source
Prevention of HIV Protease Inhibitor-Induced Dysregulation of Hepatic Lipid Metabolism by Raltegravir via Endoplasmic Reticulum Stress Signaling Pathways [PDF]
Risheng Cao+10 more
openalex +1 more source
Impact of Raltegravir on immune reconstitution and thymopoiesis in HIV‐1‐infected patients with undetectable viremia [PDF]
Carmen Garrido+6 more
openalex +1 more source